InvestorsHub Logo
Followers 37
Posts 7222
Boards Moderated 1
Alias Born 09/06/2014

Re: guardiangel post# 29853

Monday, 09/21/2015 10:12:28 AM

Monday, September 21, 2015 10:12:28 AM

Post# of 30046
"No need for the name Radient Pharmaceuticals to be mentioned on this board again you understand."

I agree. Radient Pharmaceuticals is gone.

You have to admire the way the previous AMDL/Radient officers borrowed over $10 million and ran a business for years without paying back the loans... and then buried the debt without going through the expense and hassle of a bankruptcy, resigned, and walked away.

Seems easy, in retrospect.

Will anyone develop a "second generation DR-70?" I doubt it. Radient tried for six years to find a replacement for the dwindling-supply HRP anti-fibrinogen ingredient and failed.

GCDx and the Aussies talk about "clinical trials" but they can't back up their promises with white papers or evidence of trials -- all they offer is rhetoric on a website.

UNI might have the resources... but regardless of whether they succeed or not, they have no reason to involve AMDL (or Radient) because DR-70 is off patent.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.